Artelo Biosciences, Inc.
ARTL· Nasdaq
ARTLArtelo Biosciences, Inc.
Source filing unavailable
| Metric | Q2 2021 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Net Income | -$2.25M | -$424.79K | -$798.46K | -$13.01K |
| EPS Diluted | — | -$0.40 | -$0.07 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Artelo Biosciences, Inc. · CIK 1621221 · Engraved from SEC EDGAR
